Drug developer Iambic Therapeutics, backed by Nvidia and Qatar's sovereign wealth fund, filed for a US IPO on Monday, adding to a busy slate of biotech listings. The San Diego-based company plans to list on Nasdaq under the symbol "IAM" and has raised about $461.8 million to date. J.P. Morgan, Jefferies, BofA Securities and Citigroup are underwriters.
Nvidia-backed Iambic Therapeutics files for US IPO
Source: Reuters